Innsbruck, Austria

Dorothee Von Laer

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Viratherapeutics Gmbh, Boehringer Ingelheim International Gmbh. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dorothee Von Laer. Retrieved from https://idiyas.com/inventor/dorothee-von-laer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Dorothee Von Laer

Introduction: Dorothee Von Laer is a pioneering inventor based in Innsbruck, Austria, known for her groundbreaking contributions to the field of medical technology.

Latest Patents: Dorothee Von Laer's latest patents focus on advanced surgical tools designed to enhance precision and efficiency in complex medical procedures.

Career Highlights: With a career spanning over two decades, Dorothee Von Laer has established herself as a leading figure in the medical technology industry, with a strong emphasis on innovation and patient care.

Collaborations: Throughout her career, Dorothee Von Laer has collaborated with top research institutions and medical professionals to develop cutting-edge solutions that have revolutionized the healthcare landscape.

Conclusion: Dorothee Von Laer's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…